RESP RES 润色咨询

RESPIRATORY RESEARCH

出版年份：暂无数据 年文章数：2325 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：4.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2025-04-16 残月下的孤旅 来自四川省

    不清楚

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2025-02-11 ms7000001800520529 来自山东省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：Submission received
    Submission status Date
    Submission received
    16 Oct 2024
    Technical check
    Submission status Date
    Submission is under technical check
    16 Oct 2024
    Amendment requested
    17 Oct 2024
    Amendment received
    17 Oct 2024
    Submission passed technical check
    18 Oct 2024
    Editorial assignment
    Submission status Date
    Ready for editorial assignment
    18 Oct 2024
    With editor
    Submission status Date
    Editor assigned
    18 Oct 2024
    Peer review
    Submission status Date
    First reviewer(s) invited
    05 Dec 2024
    Reviewer(s) accepted
    05 Dec 2024
    Reviewer report(s) received
    10 Dec 2024
    Revision requested
    11 Jan 2025
    Revision received
    04 Feb 2025
    Submission passed technical check
    06 Feb 2025
    First reviewer(s) invited
    06 Feb 2025
    Reviewer(s) accepted
    06 Feb 2025
    Reviewer report(s) received
    06 Feb 2025
    Submission accepted
    Submission status Date
    Submission accepted
    08 Feb 2025
    Publishing and rights
    Submission status Date
    Submission is in publishing and rights
    08 Feb 2025

    修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2024-09-28 ms9000000627278949 来自浙江省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向：呼吸病
    经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2024-09-28 ms9000000627278949 来自浙江省

    一个月接收了

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2024-03-04 ms9000001709983423 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肺癌;生信分析
    经验分享：20230913 投稿
    20230914 送审
    20231012 一审返回，审稿意见：大修，两个审稿人
    20231211 返修回杂志
    20231224 二审送回，审稿意见：小修
    20240103 返修回杂志社
    20240118 接受
    202402 在线发表

    总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。
    综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2023-08-26 kiki123 来自上海

    偏重的研究方向：肺腺癌
    经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2022-12-30 ms2000001268287157 来自辽宁省

    兄弟们，现在还这么慢吗？？5天还没分配编辑

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2022-03-25 ms9000000537367142

    14 reviewer(s) invited 是啥操作?

    16

    展开16条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2022-12-10 ms9000000537367142 来自四川省

    投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2260750, encodeId=c2b92260e50bb, content=不清楚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VPZJT5BtrnahDCMHoqOXmRiagCC5KRCWjd2iaDZNV8MLxicogTL0ku1XR1CG7d8Bs512p0Obayhad10Iq0kPExVag/132, createdBy=add52406562, createdName=残月下的孤旅, createdTime=Wed Apr 16 19:01:41 CST 2025, time=2025-04-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2251475, encodeId=fa5b22514e5e9, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Submission received<br>Submission status Date<br>Submission received<br>16 Oct 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>16 Oct 2024<br>Amendment requested<br>17 Oct 2024<br>Amendment received<br>17 Oct 2024<br>Submission passed technical check<br>18 Oct 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>18 Oct 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>18 Oct 2024<br>Peer review<br>Submission status Date<br>First reviewer(s) invited<br>05 Dec 2024<br>Reviewer(s) accepted<br>05 Dec 2024<br>Reviewer report(s) received<br>10 Dec 2024<br>Revision requested<br>11 Jan 2025<br>Revision received<br>04 Feb 2025<br>Submission passed technical check<br>06 Feb 2025<br>First reviewer(s) invited<br>06 Feb 2025<br>Reviewer(s) accepted<br>06 Feb 2025<br>Reviewer report(s) received<br>06 Feb 2025<br>Submission accepted<br>Submission status Date<br>Submission accepted<br>08 Feb 2025<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>08 Feb 2025<br><br>修改意见还是可以的，投的是基础实验的，小修，修回接着就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cc28420930, createdName=ms7000001800520529, createdTime=Tue Feb 11 15:18:10 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2228125, encodeId=92392228125a4, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：呼吸病<br>经验分享：31天接收了，呼吸病方向的，谢谢你编辑及审稿人，毕业了。 Submission history Submission received Submission status Date Submission received 25 Aug 2024 Technical check Submission status Date Submission is under technical check 25 Aug 2024 Amendment requested 26 Aug 2024 Amendment received 26 Aug 2024 Submission passed technical check 27 Aug 2024 Editorial assignment Submission status Date Ready for editorial assignment 27 Aug 2024 With editor Submission status Date Editor assigned 27 Aug 2024 Peer review Submission status Date First reviewer(s) invited 28 Aug 2024 Reviewer(s) accepted 31 Aug 2024 Reviewer report(s) received 11 Sep 2024 Revision requested 16 Sep 2024 Revision received 25 Sep 2024 Submission passed technical check 26 Sep 2024 Submission accepted Submission status Date Submission accepted 26 Sep 2024 Publishing and rights Submission status Date Submission is in publishing and rights 26 Sep 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 00:59:34 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228126, encodeId=861622281260b, content=一个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8219223114, createdName=ms9000000627278949, createdTime=Sat Sep 28 01:05:07 CST 2024, time=2024-09-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌;生信分析<br>经验分享：20230913 投稿<br>20230914 送审<br>20231012 一审返回，审稿意见：大修，两个审稿人<br>20231211 返修回杂志<br>20231224 二审送回，审稿意见：小修<br>20240103 返修回杂志社<br>20240118 接受<br>202402 在线发表<br><br>总体来说，速度算比较快了。投中的文章整体风格 是 生信 + 简单验证（免疫组化+临床队列）。<br>综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌<br>经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月 最后被拒 第一轮审稿 两个审稿人 意见友好 编辑给了大修 返修回去后编辑找不到原来的审稿人 遂重新邀请了一个 像是中国人 提的问题极度苛刻 也有点业余 果然中国人还是比较容易为难中国人 因为先前两个审稿人一直没找到 编辑遂以该审稿人意见拒稿 投稿还是蛮看运气的 如果遇到审稿人能力不行 瞎提意见的 就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向：肺囊肿<br>经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港)]
    2023-01-19 ms7000001180831335 来自香港

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向：肺囊肿
    经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。

    1

    展开1条回复
共122条页码: 1/13页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分